Perioperative use of TandemHeart percutaneous ventricular assist device in surgical repair of postinfarction XXXX .

@entity1 @entity3124 @entity1757 @entity583 @entity1455
Mortality for @entity1 presenting with @entity583 ( @entity583 ) complicated by @entity1757 ( @entity1757 ) and @entity1455 is very high even with surgical repair. We report our experience regarding utilization of TandemHeart, a percutaneous ventricular assist device (pVAD) as an adjunct to the treatment of these @entity1 . Retrospective case series study design included a total of 11 @entity1 with post- @entity583 @entity1757 and severe refractory @entity1455 who received pVAD support at our institution. Three @entity1 underwent immediate surgical repair and received pVAD support for postcardiotomy @entity1455 for 2, 4, and 7 days, respectively. However, all three died. The other eight @entity1 had pVAD implanted prior to surgical repair in order to rest the myocardium before operation. Hemodynamics improved immediately after pVAD placement, and after receiving pVAD support for 7    3 days, they underwent surgical @entity1757 repair. Their total pre- and post-surgical pVAD support was 14    4 days. All eight survived 30 days postoperatively. At 6 months postsurgery overall survival rate was 75%. Our small series of these @entity3124 @entity1 shows a trend toward better survival after immediate pVAD placement to stabilize the @entity1 and allow for myocardial maturation before surgical @entity1757 repair.
